SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-18-007185
Filing Date
2018-08-22
Accepted
2018-08-22 16:49:58
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A gemp-20171231x10ka.htm 10-K/A 67255
2 EX-31.1 gemp-20171231ex311092d71.htm EX-31.1 16358
3 EX-31.2 gemp-20171231ex312b10fb3.htm EX-31.2 15421
  Complete submission text file 0001558370-18-007185.txt   100072
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37809 | Film No.: 181032932
SIC: 2834 Pharmaceutical Preparations